FR2461710B1 - - Google Patents

Info

Publication number
FR2461710B1
FR2461710B1 FR7918357A FR7918357A FR2461710B1 FR 2461710 B1 FR2461710 B1 FR 2461710B1 FR 7918357 A FR7918357 A FR 7918357A FR 7918357 A FR7918357 A FR 7918357A FR 2461710 B1 FR2461710 B1 FR 2461710B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7918357A
Other languages
French (fr)
Other versions
FR2461710A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma SAS
Original Assignee
Laboratoires Sarget
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Sarget filed Critical Laboratoires Sarget
Priority to FR7918357A priority Critical patent/FR2461710A1/fr
Priority to US06/162,814 priority patent/US4333938A/en
Priority to EP19800450003 priority patent/EP0022737B1/fr
Priority to DE8080450003T priority patent/DE3060524D1/de
Priority to PT7154480A priority patent/PT71544A/pt
Priority to JP9613780A priority patent/JPS5618978A/ja
Priority to MA19106A priority patent/MA18907A1/fr
Priority to ES493401A priority patent/ES493401A0/es
Priority to ZA00804291A priority patent/ZA804291B/xx
Priority to CA000356312A priority patent/CA1152509A/en
Publication of FR2461710A1 publication Critical patent/FR2461710A1/fr
Application granted granted Critical
Publication of FR2461710B1 publication Critical patent/FR2461710B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7918357A 1979-07-16 1979-07-16 Nouvelles imines derivees de l'amino-5 benzodioxole-1,3 utiles comme medicaments Granted FR2461710A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7918357A FR2461710A1 (fr) 1979-07-16 1979-07-16 Nouvelles imines derivees de l'amino-5 benzodioxole-1,3 utiles comme medicaments
US06/162,814 US4333938A (en) 1979-07-16 1980-06-25 Imino derivatives of 5-aminobenzodioxole-1,3 which are useful as medicaments
DE8080450003T DE3060524D1 (en) 1979-07-16 1980-07-07 Imines derived from 5-amino-1,3-benzodioxole useful as medicines, and their preparation
EP19800450003 EP0022737B1 (fr) 1979-07-16 1980-07-07 Imines dérivées de l'amino-5 benzodioxole-1,3 utiles comme médicaments et leur préparation
PT7154480A PT71544A (fr) 1979-07-16 1980-07-11 Procede pour preparer nouvelles imines derivees de l'amino-5 benzodioxole-1,3
JP9613780A JPS5618978A (en) 1979-07-16 1980-07-14 Novel imine useful as drug and derived from 55aminoo1*33benzodioxol
MA19106A MA18907A1 (fr) 1979-07-16 1980-07-15 Nouvelles imines derivees de l'amino-5 benzodioxole-1,3 utilisees comme medicaments
ES493401A ES493401A0 (es) 1979-07-16 1980-07-15 Procedimiento de obtencion de nuevas iminas derivadas de la amino-5-benzodioxola-1, 3 utiles como medicamentos
ZA00804291A ZA804291B (en) 1979-07-16 1980-07-16 New imines derivatives of 1'amino-5 benzodioxole-1,3 useful for medicaments
CA000356312A CA1152509A (en) 1979-07-16 1980-07-16 Imino derivatives of 5-aminobenzodioxole-1, 3 which are useful as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7918357A FR2461710A1 (fr) 1979-07-16 1979-07-16 Nouvelles imines derivees de l'amino-5 benzodioxole-1,3 utiles comme medicaments

Publications (2)

Publication Number Publication Date
FR2461710A1 FR2461710A1 (fr) 1981-02-06
FR2461710B1 true FR2461710B1 (OSRAM) 1981-07-24

Family

ID=9227916

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7918357A Granted FR2461710A1 (fr) 1979-07-16 1979-07-16 Nouvelles imines derivees de l'amino-5 benzodioxole-1,3 utiles comme medicaments

Country Status (5)

Country Link
US (1) US4333938A (OSRAM)
JP (1) JPS5618978A (OSRAM)
CA (1) CA1152509A (OSRAM)
FR (1) FR2461710A1 (OSRAM)
ZA (1) ZA804291B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688271B2 (en) * 1992-07-24 1998-03-12 Regents Of The University Of California, The Drugs that enhance synaptic responses mediated by ampa receptors
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2876220A (en) * 1957-04-10 1959-03-03 Dow Chemical Co 2, 3-dichloro-n-(piperonlyidene)aniline
SE422799B (sv) * 1975-05-28 1982-03-29 Merck & Co Inc Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner
DE2630764C2 (de) 1975-07-09 1986-07-17 Société Cortial S.A., Paris N-Substituierte 3-Amino-3H-isobenzofuranone und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
FR2461710A1 (fr) 1981-02-06
US4333938A (en) 1982-06-08
ZA804291B (en) 1981-09-30
CA1152509A (en) 1983-08-23
JPS5618978A (en) 1981-02-23

Similar Documents

Publication Publication Date Title
BR8002583A (OSRAM)
BR8006808A (OSRAM)
FR2450450B3 (OSRAM)
FR2461710B1 (OSRAM)
FR2450291B1 (OSRAM)
AT364253B (OSRAM)
AU78390S (OSRAM)
AU79200S (OSRAM)
AU78271S (OSRAM)
AU78385S (OSRAM)
AU78386S (OSRAM)
AU78389S (OSRAM)
AU77763S (OSRAM)
AU78391S (OSRAM)
AU78569S (OSRAM)
AU78270S (OSRAM)
AU79557S (OSRAM)
AU79558S (OSRAM)
AU79559S (OSRAM)
AU79826S (OSRAM)
AU79918S (OSRAM)
AU79950S (OSRAM)
AU80228S (OSRAM)
BR5901094U (OSRAM)
AU77669S (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse